Tuesday, March 29, 2011

Brokerage Firm Ratings + Price Target

Updated 28-Mar-11 13:16 ET

Upgrades


CompanyTickerBrokerage FirmRatings ChangePrice Target
NVIDIANVDAJMP SecuritiesMkt Perform » Mkt Outperform$25
Encore EnergyENPRBC Capital MktsUnderperform » Sector Perform$18 » $24
ADA-ESADESWedbushNeutral » Outperform$16 » $27
IlluminaILMNAuriga U.S.AHold » Buy$75 » $75
VerizonVZRobert W. BairdNeutral » Outperform$36 » $42
MetroPCSPCSRobert W. BairdNeutral » Outperform$14 » $22
Leap WirelessLEAPRobert W. BairdNeutral » Outperform$14 » $19
AT&TTRobert W. BairdNeutral » Outperform$30 » $34

Downgrades


CompanyTickerBrokerage FirmRatings ChangePrice Target
Dr Pepper SnappleDPSStifel NicolausBuy » Hold
China-BioticsCHBTMaxim GroupBuy » Hold
Vanguard Natural ResourcesVNRRBC Capital MktsOutperform » Sector Perform$34 » $34
L-3 CommsLLLOppenheimerPerform » Underperform$85 » $83
Franklin ResourcesBENTiconderogaBuy » Neutral

Coverage Initiated


CompanyTickerBrokerage FirmRatings ChangePrice Target
Regency EnergyRGNCStifel NicolausHold
Aastrom BiosciencesASTMStifel NicolausBuy$4.50
Zuoan FashionZARBC Capital MktsOutperform$9
Leap WirelessLEAPCollins StewartHold
MetroPCSPCSCollins StewartBuy$20
Zuoan FashionZAJanney Mntgmy ScottNeutral$8

Coverage Reit/Price Tgt Changed*


CompanyTickerBrokerage FirmRatings ChangePrice Target
WW GraingerGWWBarclays CapitalEqual Weight$130 » $145
Sirona Dental SystemsSIROBarclays CapitalOverweight$55 » $58
Kinder Morgan PartnersKMPBarclays CapitalOverweight$75 » $77
Edwards LifesciencesEWBarclays CapitalOverweight$87 » $95
Darden RestaurantsDRIBarclays CapitalOverweight$57 » $60
CBSCBSBarclays CapitalEqual Weight$23 » $25
Bristol-MyersBMYBarclays CapitalOverweight$28 » $30
CreeCREEDeutsche BankHold$55 » $45
Rowan CosRDCRBC Capital MktsSector Perform$50 » $48

(a) Brokerage firm initiating coverage participated in underwriting the recent IPO.
(b) Brokerage firm resumes coverage.
(c) Brokerage firm participated in the secondary offering.
* This list of reiterations/target changes is not comprehensive.

No comments: